Products
Online Inquiry
Zapnometinib
Cat. No.:
0225LY-1298
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Zapnometinib is categorized as a MEK inhibitor.
Synonym:
ATR-002; 3,4-difluoro-2-(2-chloro-4-iodophenylaMino)-benzoic acid; PD0184264; 2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic acid; 303175-44-2; 2-(2-chloro-4-iodophenylamino)-3,4-difluorobenzoic acid; Benzoic acid, 2-[(2-chloro-4-iodophenyl)amino]-3,4-difluoro-; 2-(2-chloro-4-iodoanilino)-3,4-difluorobenzoic acid; 2-((2-Chloro-4-iodophenyl)amino)-3,4-difluorobenzoic acid
CAS No.:
303175-44-2
Compound CID:
10112191
Formula:
C13H7ClF2INO2
Formula Weight:
409.55
Specification
Targets&IC50:
MEK: 5.7 nM
Relative Density:
1.946 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Zapnometinib can be used in virology research to examine the inhibition of the MEK signaling pathway and its effect on viral replication.
Library Information
Target:
MEK
Receptor:
MEK
Pathways:
MAPK; Microbiology/Virology
Plate Number:
AOCL-17
Plate Location:
f5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
60 mg/mL; 146.5 mM
